These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11472876)

  • 1. The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures.
    Gearan T; Castillo OA; Schwarzschild MA
    Parkinsonism Relat Disord; 2001 Sep; 8(1):19-22. PubMed ID: 11472876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.
    Viswanath V; Wu Y; Boonplueang R; Chen S; Stevenson FF; Yantiri F; Yang L; Beal MF; Andersen JK
    J Neurosci; 2001 Dec; 21(24):9519-28. PubMed ID: 11739563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
    Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
    Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.
    Xia XG; Harding T; Weller M; Bieneman A; Uney JB; Schulz JB
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10433-8. PubMed ID: 11504916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons.
    Holtz WA; O'Malley KL
    J Biol Chem; 2003 May; 278(21):19367-77. PubMed ID: 12598533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).
    Koutsilieri E; Chan WW; Reinitzer D; Rausch WD
    J Neural Transm Gen Sect; 1993; 94(3):189-97. PubMed ID: 7907217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Nishi K
    Brain Res; 1997 Oct; 771(1):133-41. PubMed ID: 9383016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
    Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ
    J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
    Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
    Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
    J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo.
    Saporito MS; Thomas BA; Scott RW
    J Neurochem; 2000 Sep; 75(3):1200-8. PubMed ID: 10936203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK
    Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
    Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
    Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B; Parent A
    Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP; Agid Y
    Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease.
    Pan J; Xiao Q; Sheng CY; Hong Z; Yang HQ; Wang G; Ding JQ; Chen SD
    Neurochem Int; 2009 Jun; 54(7):418-25. PubMed ID: 19428783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.